首页> 美国卫生研究院文献>British Journal of Sports Medicine >Exercise metabolism in healthy volunteers taking celiprolol atenolol and placebo.
【2h】

Exercise metabolism in healthy volunteers taking celiprolol atenolol and placebo.

机译:在服用西酞洛尔阿替洛尔和安慰剂的健康志愿者中锻炼新陈代谢。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: Previous studies have shown that beta 1 selective agents have fewer adverse effects on exercise metabolism than nonselective beta blockers, and this has been attributed to their reduced blockade of beta 2 receptors. This study aimed at determining whether a beta blocker with partial agonist activity at beta 1 and beta 2 receptors (celiprolol) was better than a conventional beta 1 receptor-blocker (atenolol) in prolonging exercise capabilities. METHODS: After four days of treatment with celiprolol 200 mg, atenolol 50 mg, or placebo, 22 healthy volunteers exercised on a treadmill for two hours at 50% of their maximal oxygen uptake. Resting heart rate and blood pressure were recorded before and after exercise. During exercise, fat oxidation, plasma free fatty acids, glycerol, glucose, and ammonia were measured together with heart rate and perceived exertion. RESULTS: Mean exercising heart rate was significantly lower in those taking either of the beta blockers than in those taking placebo, and significantly lower for those taking atenolol rather than celiprolol. Fat oxidation was significantly lower for those taking celiprolol (38.8 (SD 12.2)%, P < 0.01) and atenolol (36.6 (15.9)%, P < 0.01) compared with placebo (45.6 (14.1)%). For the first 15 minutes of exercise, fat oxidation was significantly lower for those taking atenolol (24.6 (12.8)%, P < 0.01) than celiprolol (29.6 (14.3)%). The rise in plasma free fatty acids and glycerol during exercise was also significantly attenuated by both beta blockers in comparison with the rise in those taking placebo (P < 0.01). CONCLUSIONS: Both celiprolol and atenolol reduced fat oxidation compared with placebo. For the first 15 minutes of exercise fat oxidation was preserved by celiprolol, but not atenolol. This preservation of fat oxidation during the early part of exercise may confer some small benefit to patients who take beta blockers and intend to exercise regularly. However, we did not detect significant differences between atenolol and celiprolol in overall mean fat oxidation or perceived exertion in this study.
机译:目的:以前的研究表明,β1选择剂对运动代谢的不良影响要比非选择性β受体阻滞剂少,这归因于其对β2受体的减少。这项研究旨在确定在延长运动能力方面,对β1和β2受体(西酞洛尔)具有部分激动剂活性的β受体阻滞剂是否优于传统的β1受体阻滞剂(阿替洛尔)。方法:用头孢洛尔200 mg,阿替洛尔50 mg或安慰剂治疗4天后,22名健康志愿者在跑步机上锻炼了两个小时,其最大摄氧量为50%。运动前后记录静息心率和血压。在运动过程中,测量脂肪氧化,血浆游离脂肪酸,甘油,葡萄糖和氨气以及心律和感觉到的劳累。结果:服用任何一种β受体阻滞剂的人的平均运动心率均显着低于服用安慰剂的人,而服用阿替洛尔而不是西酞洛尔的人的平均运动心率则显着降低。与安慰剂组(45.6(14.1)%)相比,服用西立洛尔(38.8(SD 12.2)%,P <0.01)和阿替洛尔(36.6(15.9)%,P <0.01)的人的脂肪氧化显着降低。在运动的前15分钟中,服用阿替洛尔的人(24.6(12.8)%,P <0.01)的脂肪氧化明显低于头孢洛尔(29.6(14.3)%)。与服用安慰剂的人相比,两种β受体阻滞剂也显着减弱了运动中血浆游离脂肪酸和甘油的增加(P <0.01)。结论:与安慰剂相比,头孢洛尔和阿替洛尔均降低了脂肪氧化。在运动的前15分钟中,头孢洛尔可保持脂肪氧化,但阿替洛尔则不能。在运动初期保留脂肪氧化可能会给服用β受体阻滞剂并打算定期运动的患者带来一些小好处。但是,在这项研究中,我们没有发现阿替洛尔和西酞洛尔在总体平均脂肪氧化或感知的劳累方面有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号